Neptunus Fuyuan

Shenzhen Neptunus Fuyuan Pharmaceutical, a core subsidiary of the Neptunus Group, is a prominent Chinese pharmaceutical enterprise specializing in the R&D, manufacturing, and commercialization of chemical generic drugs. The company maintains a robust portfolio focused on chronic and high-incidence conditions, including cardiovascular disorders, endocrine diseases, and infectious diseases. Operating several GMP-certified production lines, Neptunus Fuyuan produces a wide array of oral solid dosages, such as tablets and capsules, for the domestic market. The company is particularly recognized for its active participation in China's national consistency evaluation process for generic drugs, ensuring bioequivalence and high quality. It serves as a critical manufacturing engine within the broader Shenzhen Neptunus Bioengineering ecosystem.